PRIA Logo™
119-hr-1806119th CongressWALLET

Triple-Negative Breast Cancer Research and Education Act of 2025

Sponsored By: Representative Morelle, Joseph D. [D-NY-25]

Introduced

Summary

Creates a coordinated federal program to expand research, public education, and clinical guidance on triple-negative breast cancer with a clear focus on minority women and health disparities. It would add a new section to the Public Health Service Act to organize those activities across federal agencies.

Show full summary
  • Families and patients: More public information on TNBC incidence, prevalence, the higher risk among minority women, and the range of treatment options for symptomatic TNBC.
  • Health care providers: The Health Resources and Services Administration would develop and distribute up-to-date clinical information so providers know about elevated risks and available treatments.
  • Researchers and institutes: The National Institutes of Health Director would coordinate and expand TNBC research across relevant institutes and offices, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, the Office of Research on Women's Health, and the National Institute on Minority Health and Health Disparities.
  • Public health partnerships: The Centers for Disease Control and Prevention may share information directly or through nonprofits, universities, and state and local agencies.
  • Funding window: The bill authorizes appropriations as needed for fiscal years 2026 through 2031.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

More NIH research on triple-negative breast cancer

If enacted, NIH would expand and better coordinate research on triple-negative breast cancer. The Office of Research on Women's Health would lead coordination across NIH. The work would pay special attention to risks and outcomes for minority women. Congress would authorize funding without a set dollar amount for fiscal years 2026 through 2031.

Public and provider education on triple-negative breast cancer

If enacted, HHS, through CDC, would create and share public information on triple-negative breast cancer. Topics would include how common it is, higher risk for minority women, and treatment options. HHS could partner with nonprofits, schools, agencies, and media to spread the word. HHS, through HRSA, would provide up-to-date guidance to health care providers. Congress would authorize funding without a set dollar amount for fiscal years 2026 through 2031.

Sponsors & CoSponsors

Sponsor

Morelle, Joseph D. [D-NY-25]

NY • D

Cosponsors

  • Rep. Bacon, Don [R-NE-2]

    NE • R

    Sponsored 3/3/2025

  • Rep. Fitzpatrick, Brian K. [R-PA-1]

    PA • R

    Sponsored 3/11/2025

  • Rep. Cherfilus-McCormick, Sheila [D-FL-20]

    FL • D

    Sponsored 3/24/2025

  • Rep. Johnson, Henry C. "Hank" [D-GA-4]

    GA • D

    Sponsored 3/26/2025

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 3/26/2025

  • Rep. Evans, Dwight [D-PA-3]

    PA • D

    Sponsored 3/31/2025

  • Rep. Tonko, Paul [D-NY-20]

    NY • D

    Sponsored 4/28/2025

  • Rep. Cohen, Steve [D-TN-9]

    TN • D

    Sponsored 6/5/2025

  • Rep. Gottheimer, Josh [D-NJ-5]

    NJ • D

    Sponsored 6/23/2025

  • Rep. Castor, Kathy [D-FL-14]

    FL • D

    Sponsored 7/16/2025

  • Rep. Thanedar, Shri [D-MI-13]

    MI • D

    Sponsored 11/7/2025

  • Rep. Mfume, Kweisi [D-MD-7]

    MD • D

    Sponsored 2/23/2026

  • Rep. Carter, Troy A. [D-LA-2]

    LA • D

    Sponsored 5/22/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation